Accuracy of dynamic computer-assisted implant surgery in fully edentulous patients: An in vitro study.

Autor: Ruiz-Romero V; DDS, MS. Master of Oral Surgery and Implantology, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona Spain., Jorba-Garcia A; DDS, MS. Master of Oral Surgery and Implantology, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona Spain., Camps-Font O; DDS, MS, PhD. Associate Professor of Oral Surgery, Faculty of Medicine and Health Sciences, University of Barcelona (Spain). Researcher at the IDIBELL Institute, Barcelona Spain., Figueiredo R; DDS, MS, PhD. Associate Professor of Oral Surgery, Faculty of Medicine and Health Sciences, University of Barcelona (Spain). Researcher at the IDIBELL Institute, Barcelona Spain. Electronic address: ruibarbosa@ub.edu., Valmaseda-Castellón E; DDS, MS, PhD. Chairman of Oral Surgery. Faculty of Medicine and Health Sciences of the University of Barcelona (Spain), Researcher at the IDIBELL Institute, Barcelona Spain.
Jazyk: angličtina
Zdroj: Journal of dentistry [J Dent] 2024 Oct; Vol. 149, pp. 105290. Date of Electronic Publication: 2024 Aug 04.
DOI: 10.1016/j.jdent.2024.105290
Abstrakt: Objectives: To compare miniscrew versus bone tracing registration methods on dental implant placement accuracy and time efficiency in edentulous jaws using a dynamic computer-assisted implant surgery (d-CAIS) system.
Methods: Twelve fully edentulous maxillary models were allocated into two groups: miniscrew tracing (MST) group, where registration was performed by tracing four miniscrews; and bone tracing (BT) group, where registration was conducted by tracing maxillary bone fiducial landmarks. Six implants were placed on each model using the X-Guide® d-CAIS system. Pre- and postoperative cone-beam computed tomography (CBCT) scans were superimposed to evaluate implant placement accuracy. The time required for registration and the overall surgery time were also recorded.
Results: Thirty-six implants were placed in each group. The MST group showed significantly lower mean angulation deviations (mean difference (MD): -3.33°; 95 % confidence interval (CI): -6.56 to -0.09); p = 0.044), 3D platform deviations (MD: -1.01 mm; 95 % CI: -1.74 to -0.29; p = 0.006), 2D platform deviations (MD: -0.97 mm; 95 % CI: -1.71 to -0.23; p = 0.010), and 3D apex deviations (MD: -1.18 mm; 95 % CI: -1.92 to -0.44; p = 0.002) versus the BT group. The overall surgery time was similar for both groups (MD: 6.10 min.; 95 % CI: -0.31 to 12.51; p = 0.06), though bone tracing required significantly more time compared with miniscrew registration (MD: 4.79 min.; 95 % CI: 2.96 to 6.62; p < 0.05).
Conclusions: Registration with MST increases the accuracy of implant placement with a d-CAIS system in edentulous jaws compared with the BT method, and slightly reduces the overall surgery time.
Clinical Significance: Miniscrew tracing registration improves implant placement accuracy in comparison with bone tracing registration.
Competing Interests: Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: The authors declare that they have no known competing financial interests or personal relationships directly related with this study. However, they would like to declare the following interests outside the submitted work: Dr. Octavi Camps-Font reports grants and non-financial support from Avinent (Santpedor, Spain), and non-financial support from Nobel Biocare (Zürich, Switzerland) outside the submitted work. Dr. Rui Figueiredo reports grants, personal fees, and non-financial support from MozoGrau (Valladolid, Spain), Avinent (Santpedor, Spain), Inibsa Dental (Lliçà de Vall, Spain), Dentaid SL (Cerdanyola del Vallés, Spain), non-financial support from Nobel Biocare (Zürich, Switzerland), personal fees from Geistlich Pharma AG (Wolhusen, Switzerland), BioHorizons Iberica (Madrid, Spain), Araguaney Dental (Barcelona, Spain), Septodont (Saint-Maur-des-fossés, France) and Laboratorios Silanes (Mexico city, Mexico) outside the submitted work. Dr. Figueiredo has also participated as a principal investigator in a randomized clinical trial sponsored by Mundipharma (Cambridge, UK) and in another clinical trial as a sub-investigator for Menarini Richerche (Florence, Italy). Dr. Eduard Valmaseda-Castellón reports grants, personal fees, and non-financial support from MozoGrau (Valladolid, Spain), Avinent (Santpedor, Spain), Inibsa Dental (Lliçà de Vall, Spain), Dentaid SL (Cerdanyola del Vallés, Spain), and personal fees from BioHorizons Iberica (Madrid, Spain) and Laboratorios Silanes (Mexico city, Mexico) outside the submitted work. Dr. Eduard Valmaseda-Castellón has also participated as a principal investigator in a randomized clinical trial sponsored by Geistlich Pharma AG (Wolhusen, Switzerland) and in another clinical trial as a sub-investigator for Mundipharma (Cambridge, UK).
(Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: